Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 261 entries
Sorted by: Best Match Show Resources per page
Isolated subcutaneous sarcoid-like granulomatous inflammation occurring at injection sites: 3 patients treated successfully with minocycline.

JAAD case reports

Abbott J, Taylor LA, Wanat KA, Rosenbach M.
PMID: 28203624
JAAD Case Rep. 2017 Feb 04;3(1):74-77. doi: 10.1016/j.jdcr.2016.12.004. eCollection 2017 Jan.

No abstract available.

Cite
Abbott J, Taylor LA, Wanat KA, et al. Isolated subcutaneous sarcoid-like granulomatous inflammation occurring at injection sites: 3 patients treated successfully with minocycline. JAAD Case Rep. 2017;3(1):74-77doi: 10.1016/j.jdcr.2016.12.004.
Abbott, J., Taylor, L. A., Wanat, K. A., & Rosenbach, M. (2017). Isolated subcutaneous sarcoid-like granulomatous inflammation occurring at injection sites: 3 patients treated successfully with minocycline. JAAD case reports, 3(1), 74-77. https://doi.org/10.1016/j.jdcr.2016.12.004
Abbott, James, et al. "Isolated subcutaneous sarcoid-like granulomatous inflammation occurring at injection sites: 3 patients treated successfully with minocycline." JAAD case reports vol. 3,1 (2017): 74-77. doi: https://doi.org/10.1016/j.jdcr.2016.12.004
Abbott J, Taylor LA, Wanat KA, Rosenbach M. Isolated subcutaneous sarcoid-like granulomatous inflammation occurring at injection sites: 3 patients treated successfully with minocycline. JAAD Case Rep. 2017 Feb 04;3(1):74-77. doi: 10.1016/j.jdcr.2016.12.004. eCollection 2017 Jan. PMID: 28203624; PMCID: PMC5294676.
Copy Download .nbib Format: NLM
Nonhealing Right Lower Leg Ulcer: Challenge.

The American Journal of dermatopathology

Blue E, Abbott J, Laggis C, Duffy K, Sontheimer R, Klein S.
PMID: 31592863
Am J Dermatopathol. 2021 Jan 01;43(1):e3-e4. doi: 10.1097/DAD.0000000000001538.

No abstract available.

Cite
Blue E, Abbott J, Laggis C, et al. Nonhealing Right Lower Leg Ulcer: Challenge. Am J Dermatopathol. 2021;43(1):e3-e4doi: 10.1097/DAD.0000000000001538.
Blue, E., Abbott, J., Laggis, C., Duffy, K., Sontheimer, R., & Klein, S. (2021). Nonhealing Right Lower Leg Ulcer: Challenge. The American Journal of dermatopathology, 43(1), e3-e4. https://doi.org/10.1097/DAD.0000000000001538
Blue, Elliot, et al. "Nonhealing Right Lower Leg Ulcer: Challenge." The American Journal of dermatopathology vol. 43,1 (2021): e3-e4. doi: https://doi.org/10.1097/DAD.0000000000001538
Blue E, Abbott J, Laggis C, Duffy K, Sontheimer R, Klein S. Nonhealing Right Lower Leg Ulcer: Challenge. Am J Dermatopathol. 2021 Jan 01;43(1):e3-e4. doi: 10.1097/DAD.0000000000001538. PMID: 31592863.
Copy Download .nbib Format: NLM
You've got the power.

Nature

Logan T, Arnott J.
PMID: 32080590
Nature. 2017 Nov;551(7681):531. doi: 10.1038/d41586-017-07261-1.

No abstract available.

Cite
Logan T, Arnott J. You've got the power. Nature. 2017;551(7681):531doi: 10.1038/d41586-017-07261-1.
Logan, T., & Arnott, J. (2017). You've got the power. Nature, 551(7681), 531. https://doi.org/10.1038/d41586-017-07261-1
Logan, Tom, and Arnott, James. "You've got the power." Nature vol. 551,7681 (2017): 531. doi: https://doi.org/10.1038/d41586-017-07261-1
Logan T, Arnott J. You've got the power. Nature. 2017 Nov;551(7681):531. doi: 10.1038/d41586-017-07261-1. PMID: 32080590.
Copy Download .nbib Format: NLM
The expression of genes contributing to pancreatic adenocarcinoma progression is influenced by the respective environment.

Genes & cancer

Sagini MN, Zepp M, Bergmann F, Bozza M, Harbottle R, Berger MR.
PMID: 30108682
Genes Cancer. 2018 Mar;9(3):114-129. doi: 10.18632/genesandcancer.173.

Pancreatic adenocarcinoma is a highly aggressive malignancy with dismal prognosis and limited curative options. We investigated the influence of organ environments on gene expression in RNU rats by orthotopic and intraportal infusion of Suit2-007

Cite
Sagini MN, Zepp M, Bergmann F, et al. The expression of genes contributing to pancreatic adenocarcinoma progression is influenced by the respective environment. Genes Cancer. 2018;9(3):114-129doi: 10.18632/genesandcancer.173.
Sagini, M. N., Zepp, M., Bergmann, F., Bozza, M., Harbottle, R., & Berger, M. R. (2018). The expression of genes contributing to pancreatic adenocarcinoma progression is influenced by the respective environment. Genes & cancer, 9(3), 114-129. https://doi.org/10.18632/genesandcancer.173
Sagini, Micah N, et al. "The expression of genes contributing to pancreatic adenocarcinoma progression is influenced by the respective environment." Genes & cancer vol. 9,3 (2018): 114-129. doi: https://doi.org/10.18632/genesandcancer.173
Sagini MN, Zepp M, Bergmann F, Bozza M, Harbottle R, Berger MR. The expression of genes contributing to pancreatic adenocarcinoma progression is influenced by the respective environment. Genes Cancer. 2018 Mar;9(3):114-129. doi: 10.18632/genesandcancer.173. PMID: 30108682; PMCID: PMC6086001.
Copy Download .nbib Format: NLM
Iatrogenic calcinosis cutis secondary to calcium chloride successfully treated with topical sodium thiosulfate.

JAAD case reports

Abbott J, Kowalski EH, Klein S, DeShazo R, Hull CM.
PMID: 32149171
JAAD Case Rep. 2020 Feb 19;6(3):181-183. doi: 10.1016/j.jdcr.2019.12.017. eCollection 2020 Mar.

No abstract available.

Cite
Abbott J, Kowalski EH, Klein S, et al. Iatrogenic calcinosis cutis secondary to calcium chloride successfully treated with topical sodium thiosulfate. JAAD Case Rep. 2020;6(3):181-183doi: 10.1016/j.jdcr.2019.12.017.
Abbott, J., Kowalski, E. H., Klein, S., DeShazo, R., & Hull, C. M. (2020). Iatrogenic calcinosis cutis secondary to calcium chloride successfully treated with topical sodium thiosulfate. JAAD case reports, 6(3), 181-183. https://doi.org/10.1016/j.jdcr.2019.12.017
Abbott, James, et al. "Iatrogenic calcinosis cutis secondary to calcium chloride successfully treated with topical sodium thiosulfate." JAAD case reports vol. 6,3 (2020): 181-183. doi: https://doi.org/10.1016/j.jdcr.2019.12.017
Abbott J, Kowalski EH, Klein S, DeShazo R, Hull CM. Iatrogenic calcinosis cutis secondary to calcium chloride successfully treated with topical sodium thiosulfate. JAAD Case Rep. 2020 Feb 19;6(3):181-183. doi: 10.1016/j.jdcr.2019.12.017. eCollection 2020 Mar. PMID: 32149171; PMCID: PMC7033297.
Copy Download .nbib Format: NLM
Impact and acceptability of HIV self-testing for trans men and trans women: A mixed-methods subgroup analysis of the SELPHI randomised controlled trial and process evaluation in England and Wales.

EClinicalMedicine

Witzel TC, Wright T, McCabe L, Gabriel MM, Wolton A, Gafos M, Ward D, Lampe FC, Phillips AN, Trevelion R, Collaco-Moraes Y, Harbottle J, Speakman A, Bonell C, Dunn DD, McCormack S, Burns FM, Weatherburn P, Rodger AJ.
PMID: 33681732
EClinicalMedicine. 2021 Feb 11;32:100700. doi: 10.1016/j.eclinm.2020.100700. eCollection 2021 Feb.

BACKGROUND: Globally, trans people are disproportionately affected by HIV, but research on strategies to increase testing are limited. SELPHI is a randomised-controlled-trial (RCT) of 10,135 METHODS: SELPHI recruited using social networking and trans focused social media. Participants were randomised...

Cite
Witzel TC, Wright T, McCabe L, et al. Impact and acceptability of HIV self-testing for trans men and trans women: A mixed-methods subgroup analysis of the SELPHI randomised controlled trial and process evaluation in England and Wales. EClinicalMedicine. 2021;32:100700doi: 10.1016/j.eclinm.2020.100700.
Witzel, T. C., Wright, T., McCabe, L., Gabriel, M. M., Wolton, A., Gafos, M., Ward, D., Lampe, F. C., Phillips, A. N., Trevelion, R., Collaco-Moraes, Y., Harbottle, J., Speakman, A., Bonell, C., Dunn, D. D., McCormack, S., Burns, F. M., Weatherburn, P., & Rodger, A. J. (2021). Impact and acceptability of HIV self-testing for trans men and trans women: A mixed-methods subgroup analysis of the SELPHI randomised controlled trial and process evaluation in England and Wales. EClinicalMedicine, 32100700. https://doi.org/10.1016/j.eclinm.2020.100700
Witzel, T Charles, et al. "Impact and acceptability of HIV self-testing for trans men and trans women: A mixed-methods subgroup analysis of the SELPHI randomised controlled trial and process evaluation in England and Wales." EClinicalMedicine vol. 32 (2021): 100700. doi: https://doi.org/10.1016/j.eclinm.2020.100700
Witzel TC, Wright T, McCabe L, Gabriel MM, Wolton A, Gafos M, Ward D, Lampe FC, Phillips AN, Trevelion R, Collaco-Moraes Y, Harbottle J, Speakman A, Bonell C, Dunn DD, McCormack S, Burns FM, Weatherburn P, Rodger AJ. Impact and acceptability of HIV self-testing for trans men and trans women: A mixed-methods subgroup analysis of the SELPHI randomised controlled trial and process evaluation in England and Wales. EClinicalMedicine. 2021 Feb 11;32:100700. doi: 10.1016/j.eclinm.2020.100700. eCollection 2021 Feb. PMID: 33681732; PMCID: PMC7910695.
Copy Download .nbib Format: NLM
Author Correction: The incidence and clinical analysis of non‑melanoma skin cancer.

Scientific reports

Ciążyńska M, Kamińska-Winciorek G, Lange D, Lewandowski B, Reich A, Sławińska M, Pabianek M, Szczepaniak K, Hankiewicz A, Ułańska M, Morawiec J, Błasińska-Morawiec M, Morawiec Z, Piekarski J, Nejc D, Brodowski R, Zaryczańska A, Sobjanek M, Nowicki RJ, Owczarek W, Słowińska M, Wróbel K, Bieniek A, Woźniacka A, Skibińska M, Narbutt J, Niemczyk W, Ciążyński K, Lesiak A.
PMID: 34321505
Sci Rep. 2021 Jul 28;11(1):15705. doi: 10.1038/s41598-021-94435-7.

No abstract available.

Cite
Ciążyńska M, Kamińska-Winciorek G, Lange D, et al. Author Correction: The incidence and clinical analysis of non‑melanoma skin cancer. Sci Rep. 2021;11(1):15705doi: 10.1038/s41598-021-94435-7.
Ciążyńska, M., Kamińska-Winciorek, G., Lange, D., Lewandowski, B., Reich, A., Sławińska, M., Pabianek, M., Szczepaniak, K., Hankiewicz, A., Ułańska, M., Morawiec, J., Błasińska-Morawiec, M., Morawiec, Z., Piekarski, J., Nejc, D., Brodowski, R., Zaryczańska, A., Sobjanek, M., Nowicki, R. J., Owczarek, W., Słowińska, M., Wróbel, K., Bieniek, A., Woźniacka, A., Skibińska, M., Narbutt, J., Niemczyk, W., Ciążyński, K., & Lesiak, A. (2021). Author Correction: The incidence and clinical analysis of non‑melanoma skin cancer. Scientific reports, 11(1), 15705. https://doi.org/10.1038/s41598-021-94435-7
Ciążyńska, Magdalena, et al. "Author Correction: The incidence and clinical analysis of non‑melanoma skin cancer." Scientific reports vol. 11,1 (2021): 15705. doi: https://doi.org/10.1038/s41598-021-94435-7
Ciążyńska M, Kamińska-Winciorek G, Lange D, Lewandowski B, Reich A, Sławińska M, Pabianek M, Szczepaniak K, Hankiewicz A, Ułańska M, Morawiec J, Błasińska-Morawiec M, Morawiec Z, Piekarski J, Nejc D, Brodowski R, Zaryczańska A, Sobjanek M, Nowicki RJ, Owczarek W, Słowińska M, Wróbel K, Bieniek A, Woźniacka A, Skibińska M, Narbutt J, Niemczyk W, Ciążyński K, Lesiak A. Author Correction: The incidence and clinical analysis of non‑melanoma skin cancer. Sci Rep. 2021 Jul 28;11(1):15705. doi: 10.1038/s41598-021-94435-7. PMID: 34321505; PMCID: PMC8319379.
Copy Download .nbib Format: NLM
The influence of tumour necrosis factor α inhibitors treatment - etanercept on serum concentration of biomarkers of inflammation and cartilage turnover in psoriatic arthritis patients.

Postepy dermatologii i alergologii

Waszczykowski M, Bednarski I, Lesiak A, Waszczykowska E, Narbutt J, Fabiś J.
PMID: 33603621
Postepy Dermatol Alergol. 2020 Dec;37(6):995-1000. doi: 10.5114/ada.2020.96705. Epub 2020 Jul 14.

INTRODUCTION: Effective treatment in psoriatic arthritis (PsA) patients can protect them from severe musculoskeletal complications. For appropriate monitoring of anti-tumour necrosis factor α (anti-TNF-α) treatment in PsA, specific biomarkers are needed.AIM: To investigate whether biological treatment with anti-TNF-α (etanercept...

Cite
Waszczykowski M, Bednarski I, Lesiak A, et al. The influence of tumour necrosis factor α inhibitors treatment - etanercept on serum concentration of biomarkers of inflammation and cartilage turnover in psoriatic arthritis patients. Postepy Dermatol Alergol. 2020;37(6):995-1000doi: 10.5114/ada.2020.96705.
Waszczykowski, M., Bednarski, I., Lesiak, A., Waszczykowska, E., Narbutt, J., & Fabiś, J. (2020). The influence of tumour necrosis factor α inhibitors treatment - etanercept on serum concentration of biomarkers of inflammation and cartilage turnover in psoriatic arthritis patients. Postepy dermatologii i alergologii, 37(6), 995-1000. https://doi.org/10.5114/ada.2020.96705
Waszczykowski, Michał, et al. "The influence of tumour necrosis factor α inhibitors treatment - etanercept on serum concentration of biomarkers of inflammation and cartilage turnover in psoriatic arthritis patients." Postepy dermatologii i alergologii vol. 37,6 (2020): 995-1000. doi: https://doi.org/10.5114/ada.2020.96705
Waszczykowski M, Bednarski I, Lesiak A, Waszczykowska E, Narbutt J, Fabiś J. The influence of tumour necrosis factor α inhibitors treatment - etanercept on serum concentration of biomarkers of inflammation and cartilage turnover in psoriatic arthritis patients. Postepy Dermatol Alergol. 2020 Dec;37(6):995-1000. doi: 10.5114/ada.2020.96705. Epub 2020 Jul 14. PMID: 33603621; PMCID: PMC7874864.
Copy Download .nbib Format: NLM
Tumor of the Nose - A Rare Manifestation of a Metastatic Lung Cancer.

Clinical, cosmetic and investigational dermatology

Bolewska A, Słowińska M, Błońska A, Ceryn J, Grala B, Narbutt J, Ciążyńska M, Małecki W, Skibińska M, Lesiak A, Paluchowska E, Owczarek W.
PMID: 34584435
Clin Cosmet Investig Dermatol. 2021 Sep 21;14:1311-1318. doi: 10.2147/CCID.S318748. eCollection 2021.

Lung cancer most often metastasizes to the central nervous system, bone and liver. Although metastases to the skin are quite rare, it is estimated that they may be the first clinical manifestation of this disease in 0.7%-12% of cases....

Cite
Bolewska A, Słowińska M, Błońska A, et al. Tumor of the Nose - A Rare Manifestation of a Metastatic Lung Cancer. Clin Cosmet Investig Dermatol. 2021;14:1311-1318doi: 10.2147/CCID.S318748.
Bolewska, A., Słowińska, M., Błońska, A., Ceryn, J., Grala, B., Narbutt, J., Ciążyńska, M., Małecki, W., Skibińska, M., Lesiak, A., Paluchowska, E., & Owczarek, W. (2021). Tumor of the Nose - A Rare Manifestation of a Metastatic Lung Cancer. Clinical, cosmetic and investigational dermatology, 141311-1318. https://doi.org/10.2147/CCID.S318748
Bolewska, Aleksandra, et al. "Tumor of the Nose - A Rare Manifestation of a Metastatic Lung Cancer." Clinical, cosmetic and investigational dermatology vol. 14 (2021): 1311-1318. doi: https://doi.org/10.2147/CCID.S318748
Bolewska A, Słowińska M, Błońska A, Ceryn J, Grala B, Narbutt J, Ciążyńska M, Małecki W, Skibińska M, Lesiak A, Paluchowska E, Owczarek W. Tumor of the Nose - A Rare Manifestation of a Metastatic Lung Cancer. Clin Cosmet Investig Dermatol. 2021 Sep 21;14:1311-1318. doi: 10.2147/CCID.S318748. eCollection 2021. PMID: 34584435; PMCID: PMC8464336.
Copy Download .nbib Format: NLM
Development of a Health Information Technology Tool for Behavior Change to Address Obesity and Prevent Chronic Disease Among Adolescents: Designing for Dissemination and Sustainment Using the ORBIT Model.

Frontiers in digital health

Kepper MM, Walsh-Bailey C, Brownson RC, Kwan BM, Morrato EH, Garbutt J, de Las Fuentes L, Glasgow RE, Lopetegui MA, Foraker R.
PMID: 34713122
Front Digit Health. 2021 Mar 10;3:648777. doi: 10.3389/fdgth.2021.648777. eCollection 2021.

Health information technology (HIT) has not been broadly adopted for use in outpatient healthcare settings to effectively address obesity in youth, especially among disadvantaged populations that face greater barriers to good health. A well-designed HIT tool can deliver behavior...

Cite
Kepper MM, Walsh-Bailey C, Brownson RC, et al. Development of a Health Information Technology Tool for Behavior Change to Address Obesity and Prevent Chronic Disease Among Adolescents: Designing for Dissemination and Sustainment Using the ORBIT Model. Front Digit Health. 2021;3:648777doi: 10.3389/fdgth.2021.648777.
Kepper, M. M., Walsh-Bailey, C., Brownson, R. C., Kwan, B. M., Morrato, E. H., Garbutt, J., de Las Fuentes, L., Glasgow, R. E., Lopetegui, M. A., & Foraker, R. (2021). Development of a Health Information Technology Tool for Behavior Change to Address Obesity and Prevent Chronic Disease Among Adolescents: Designing for Dissemination and Sustainment Using the ORBIT Model. Frontiers in digital health, 3648777. https://doi.org/10.3389/fdgth.2021.648777
Kepper, Maura M, et al. "Development of a Health Information Technology Tool for Behavior Change to Address Obesity and Prevent Chronic Disease Among Adolescents: Designing for Dissemination and Sustainment Using the ORBIT Model." Frontiers in digital health vol. 3 (2021): 648777. doi: https://doi.org/10.3389/fdgth.2021.648777
Kepper MM, Walsh-Bailey C, Brownson RC, Kwan BM, Morrato EH, Garbutt J, de Las Fuentes L, Glasgow RE, Lopetegui MA, Foraker R. Development of a Health Information Technology Tool for Behavior Change to Address Obesity and Prevent Chronic Disease Among Adolescents: Designing for Dissemination and Sustainment Using the ORBIT Model. Front Digit Health. 2021 Mar 10;3:648777. doi: 10.3389/fdgth.2021.648777. eCollection 2021. PMID: 34713122; PMCID: PMC8521811.
Copy Download .nbib Format: NLM
Increasing numbers of harbour seals and grey seals in the Solent.

Ecology and evolution

Castles R, Woods F, Hughes P, Arnott J, MacCallum L, Marley S.
PMID: 34938454
Ecol Evol. 2021 Nov 18;11(23):16524-16536. doi: 10.1002/ece3.8167. eCollection 2021 Dec.

Harbour seals (

Cite
Castles R, Woods F, Hughes P, et al. Increasing numbers of harbour seals and grey seals in the Solent. Ecol Evol. 2021;11(23):16524-16536doi: 10.1002/ece3.8167.
Castles, R., Woods, F., Hughes, P., Arnott, J., MacCallum, L., & Marley, S. (2021). Increasing numbers of harbour seals and grey seals in the Solent. Ecology and evolution, 11(23), 16524-16536. https://doi.org/10.1002/ece3.8167
Castles, Robyne, et al. "Increasing numbers of harbour seals and grey seals in the Solent." Ecology and evolution vol. 11,23 (2021): 16524-16536. doi: https://doi.org/10.1002/ece3.8167
Castles R, Woods F, Hughes P, Arnott J, MacCallum L, Marley S. Increasing numbers of harbour seals and grey seals in the Solent. Ecol Evol. 2021 Nov 18;11(23):16524-16536. doi: 10.1002/ece3.8167. eCollection 2021 Dec. PMID: 34938454; PMCID: PMC8668788.
Copy Download .nbib Format: NLM
"PROUD to have been involved": an evaluation of participant and community involvement in the PROUD HIV prevention trial.

Research involvement and engagement

Gafos M, South A, Hanley B, Brodnicki E, Hodson M, McCormack S, Witzel TC, Harbottle J, Vale C.
PMID: 32322408
Res Involv Engagem. 2020 Apr 17;6:13. doi: 10.1186/s40900-020-00189-3. eCollection 2020.

BACKGROUND: The PROUD trial, a HIV prevention trial in men who have sex with men and trans women, set out to involve community representatives and trial participants in several ways. PROUD also aimed to evaluate participant involvement, to learn...

Cite
Gafos M, South A, Hanley B, et al. "PROUD to have been involved": an evaluation of participant and community involvement in the PROUD HIV prevention trial. Res Involv Engagem. 2020;6:13doi: 10.1186/s40900-020-00189-3.
Gafos, M., South, A., Hanley, B., Brodnicki, E., Hodson, M., McCormack, S., Witzel, T. C., Harbottle, J., & Vale, C. (2020). "PROUD to have been involved": an evaluation of participant and community involvement in the PROUD HIV prevention trial. Research involvement and engagement, 613. https://doi.org/10.1186/s40900-020-00189-3
Gafos, Mitzy, et al. ""PROUD to have been involved": an evaluation of participant and community involvement in the PROUD HIV prevention trial." Research involvement and engagement vol. 6 (2020): 13. doi: https://doi.org/10.1186/s40900-020-00189-3
Gafos M, South A, Hanley B, Brodnicki E, Hodson M, McCormack S, Witzel TC, Harbottle J, Vale C. "PROUD to have been involved": an evaluation of participant and community involvement in the PROUD HIV prevention trial. Res Involv Engagem. 2020 Apr 17;6:13. doi: 10.1186/s40900-020-00189-3. eCollection 2020. PMID: 32322408; PMCID: PMC7164163.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 261 entries